Literature DB >> 24503662

Iatrogenic dependence of anabolic-androgenic steroid in an Indian non-athletic woman.

Adarsh Tripathi1, Bheemsain Tekkalaki, Shashwat Saxena, Himanshu Dandu.   

Abstract

Anabolic-androgenic steroids (AAS) are increasingly being used by athletes and youngsters to become masculine and to loose body fat. Long-term consumption of AAS causes multiple physical and psychological morbidities. Research has also concluded that AAS have addictive potential and AAS abuse is commonly found with other substance abuse. Abuse of AAS is rare in eastern countries. Abuse among women is even rarer. Here is a case report of an Indian woman, who was prescribed nandrolone decanoate injections by an unqualified medical practitioner to treat multiple non-specific somatic pains and reported weakness, leading to dependence for nandrolonedecanoate. This case report supports the research finding of abuse potential of AAS, raises concern about the need for spreading the awareness about AAS abuse among medical professionals, regulating medical practice by unqualified practitioners, and strict legal check against AAS availability in developing countries.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24503662      PMCID: PMC3918605          DOI: 10.1136/bcr-2013-202472

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

1.  The mental health workforce gap in low- and middle-income countries: a needs-based approach.

Authors:  Tim A Bruckner; Richard M Scheffler; Gordon Shen; Jangho Yoon; Dan Chisholm; Jodi Morris; Brent D Fulton; Mario R Dal Poz; Shekhar Saxena
Journal:  Bull World Health Organ       Date:  2010-11-22       Impact factor: 9.408

Review 2.  Treatment of anabolic-androgenic steroid dependence: Emerging evidence and its implications.

Authors:  Gen Kanayama; Kirk J Brower; Ruth I Wood; James I Hudson; Harrison G Pope
Journal:  Drug Alcohol Depend       Date:  2010-02-25       Impact factor: 4.492

Review 3.  Illicit anabolic-androgenic steroid use.

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Horm Behav       Date:  2009-09-18       Impact factor: 3.587

Review 4.  Anabolic-androgenic steroid dependence? Insights from animals and humans.

Authors:  Ruth I Wood
Journal:  Front Neuroendocrinol       Date:  2008-01-03       Impact factor: 8.606

Review 5.  Anabolic-androgenic steroid dependence: an emerging disorder.

Authors:  Gen Kanayama; Kirk J Brower; Ruth I Wood; James I Hudson; Harrison G Pope
Journal:  Addiction       Date:  2009-12       Impact factor: 6.526

6.  Anabolic-androgenic steroid use and involvement in violent behavior in a nationally representative sample of young adult males in the United States.

Authors:  Kevin M Beaver; Michael G Vaughn; Matt Delisi; John Paul Wright
Journal:  Am J Public Health       Date:  2008-10-15       Impact factor: 9.308

7.  Issues for DSM-V: clarifying the diagnostic criteria for anabolic-androgenic steroid dependence.

Authors:  Gen Kanayama; Kirk J Brower; Ruth I Wood; James I Hudson; Harrison G Pope
Journal:  Am J Psychiatry       Date:  2009-06       Impact factor: 18.112

Review 8.  Anabolic steroid abuse: psychiatric and physical costs.

Authors:  Farid Talih; Omar Fattal; Donald Malone
Journal:  Cleve Clin J Med       Date:  2007-05       Impact factor: 2.321

  8 in total
  2 in total

1.  The Molecular Quality and Mitochondrial Activity of Porcine Cumulus-Oocyte Complexes Are Affected by Their Exposure to Three Endocrine-Active Compounds under 3D In Vitro Maturation Conditions.

Authors:  Gabriela Gorczyca; Kamil Wartalski; Marek Romek; Marcin Samiec; Małgorzata Duda
Journal:  Int J Mol Sci       Date:  2022-04-20       Impact factor: 6.208

2.  Nandrolone Decanoate: Use, Abuse and Side Effects.

Authors:  Federico Giuseppe Patanè; Aldo Liberto; Andreana Nicoletta Maria Maglitto; Pasquale Malandrino; Massimiliano Esposito; Francesco Amico; Giuseppe Cocimano; Giuseppe Li Rosi; Dario Condorelli; Nunzio Di Nunno; Angelo Montana
Journal:  Medicina (Kaunas)       Date:  2020-11-11       Impact factor: 2.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.